tradingkey.logo
tradingkey.logo
Suchen

Conexeu Sciences Ord Shs

CNXU
Zur Watchlist hinzufügen
2.180USD
0.0000.00%
Handelsschluss 11-13 16:00(ET)
67.21MMarktkapitalisierung
0.00KGV TTM

Über Conexeu Sciences Ord Shs Unternehmen

Conexeu Sciences Inc. is an early-stage medical technology company. The Company is focused on developing regenerative biomaterials that address significant needs in wound care, dentistry, and aesthetics. The Company is focused on providing physicians with device-based solutions for healing, restoring soft tissue, and improving patient outcomes across multiple clinical settings. Its core device candidate, CXU, is a temperature-responsive ECM scaffold formulation intended to transition in-situ to a gel-like extra cellular matrix (ECM) within approximately minutes (Ten-Minute Tissue). The Company operates and manages its business in one operating segment, which is developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics.

Conexeu Sciences Ord Shs Profil

Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -

Führungskräfte von Conexeu Sciences Ord Shs

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Jeff Sharpe
Mr. Jeff Sharpe
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Steve D. Inouye
Mr. Steve D. Inouye
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Ms. Ana Bastiani
Ms. Ana Bastiani
Director
Director
--
--
Ms. April Burke
Ms. April Burke
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Conexeu Sciences Ord Shs?

Die fünf größten Anteilseigner von Conexeu Sciences Ord Shs sind: Mr. David Bogart
tradingkey.logo
Risikohinweis: Unsere Website und mobile App bieten lediglich allgemeine Informationen zu bestimmten Anlageprodukten. Finsights stellt keine Finanzberatung oder Empfehlung für ein Anlageprodukt bereit, und die Bereitstellung solcher Informationen darf nicht als Finanzberatung durch Finsights ausgelegt werden.
Anlageprodukte unterliegen erheblichen Anlagerisiken, einschließlich des möglichen Verlusts des investierten Kapitals und sind möglicherweise nicht für jeden geeignet. Die vergangene Wertentwicklung von Anlageprodukten ist nicht unbedingt ein Hinweis auf deren zukünftige Wertentwicklung.
Finsights kann Drittanbietern oder Partnern erlauben, Werbung auf unserer Website oder in unserer mobilen App oder in Teilen davon zu platzieren oder bereitzustellen. Finsights kann für diese Anzeigenvergütung erhalten, basierend auf Ihrer Interaktion mit den Werbeanzeigen.
© Urheberrecht: FINSIGHTS MEDIA PTE. LTD. Alle Rechte vorbehalten.